Opportunities and challenges in the Latin American pharmaceutical industry


Despite competition from both local and international players, the Latin American pharmaceutical market has experienced a steady growth in recent years. The regulatory landscape in Latin America presents a blend of challenges and opportunities for pharmaceutical investment and expansion. Despite variations in regulatory systems across the region, concerted efforts have been made to fortify regulatory frameworks, establish quality review mechanisms, and adopt risk-based approaches. Initiatives like the EU-Mercosur agreement and the development of a Latin American Technical Core Dossier are geared towards simplifying regulatory procedures and fostering harmonisation, which in turn, benefits both pharmaceutical companies, national health authorities and patients.

How to read this journal article 

Thank you for visiting Regulatory Rapporteur. Journal articles are restricted to registered users and TOPRA members.

Already a member or have an account? Sign in.


Free access to selected content

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

  • Create your own library to save your favourite content.
Create a free account

2. Members login

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.



Special offer on
TOPRA membership

Join TOPRA today and get membership until the end of 2025 for the exclusive rate of £290.

In addition to unlimited access to Regulatory Rapporteur content, as a TOPRA member you will also be able to enjoy a wide range of benefits including career boosting resources, savings on our events and training, and access to our regional networks and special interest groups.

This offer ends 31 July 2024

Become a member